Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06146257
Title A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors GluBio Therapeutics Inc.
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.